The National Oncologic PET Registry
NCT00868582 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 333000
Last updated 2020-08-25
Summary
The Centers for Medicare \& Medicaid Services (CMS), as the Federal agency that administers the Medicare program, only pays for positron emission tomography (PET) scans in patients with cancer for certain reasons and for certain types of cancer. This study was developed to help CMS determine if they should pay for PET scans for additional reasons and additional types of cancer. In order to collect the information needed to decide which other types of cancer should be covered by Medicare, CMS will provide payment for the otherwise non-covered PET scans of patients who are properly registered with the National Oncologic PET Registry (NOPR). This information will then be analyzed to determine the effect PET scans had on the way physicians planned to treat their patients.
Conditions
Interventions
- OTHER
-
PET scanning in cancer
Collection of institutional practice PET imaging data
Sponsors & Collaborators
-
World Molecular Imaging Society (formerly Academy of Molecular Imaging)
collaborator UNKNOWN -
American College of Radiology Imaging Network
lead NETWORK
Principal Investigators
-
Bruce Hillner, MD · Virginia Commonwealth University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-05-31
- Primary Completion
- 2020-12-31
- Completion
- 2021-06-30
Countries
- United States
Study Locations
More Related Trials
-
PET/MR in Radiotherapy for Head and Neck Cancer Pilot
NCT02952625 ·Status: COMPLETED ·Phase: NA
-
Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
NCT00351728 ·Status: COMPLETED
-
Imaging Correlates of Renal Cell Carcinoma Biological Features
NCT01665703 ·Status: COMPLETED ·Phase: NA
-
In-Room PET in Proton Radiation Therapy
NCT01228448 ·Status: COMPLETED ·Phase: NA
-
Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer
NCT00005666 ·Status: COMPLETED ·Phase: NA
-
68Ga-N188 PET/CT Imaging in Malignancy
NCT05593107 ·Status: RECRUITING ·Phase: NA
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
MRI Optimization Study in Stage III NSCLC
NCT02076282 ·Status: UNKNOWN
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer
NCT03327883 ·Status: COMPLETED
-
68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors
NCT07331532 ·Status: RECRUITING
-
Detection of Bone Marrow Metastases With Magnetic Resonance Imaging
NCT03876392 ·Status: UNKNOWN ·Phase: NA
-
[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer
NCT06165874 ·Status: RECRUITING ·Phase: NA
-
68Ga-PSMA PET in the Renal Cell Carcinoma
NCT04987086 ·Status: RECRUITING ·Phase: NA
-
PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas
NCT03076333 ·Status: COMPLETED ·Phase: NA
-
CD70-targeted immunoPET Imaging of Malignant Cancers
NCT06852638 ·Status: RECRUITING ·Phase: PHASE2
-
Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging
NCT00612326 ·Status: COMPLETED
-
MPDL3280A-imaging-IST-UMCG
NCT02453984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
NCT04588064 ·Status: COMPLETED ·Phase: NA
-
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study
NCT00686465 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy for Melanoma
NCT00912730 ·Status: COMPLETED
-
A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.
NCT07319897 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Renal Tumour Imaging Using MRI
NCT07173140 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers
NCT02966574 ·Status: UNKNOWN ·Phase: NA